Results of the POSEIDON trial presented at TCT 2012

Hydration based on ventricular pressure is effective in reducing kidney damage in patients undergoing cardiac catheterization

2012-10-25

(Press-News.org) MIAMI, FL – OCTOBER 25, 2012 – A hydration regimen tailored to the patient's fluid status was effective in reducing damage to kidneys in patients undergoing cardiac catheterization, according to a study presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation. TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.

Contrast-induced acute kidney injury (CI-AKI), or contrast-induced nephropathy, refers to kidney damage that may occur due to the use of contrast dye that is necessary for visualization during catheterization and other procedures. Hydration remains the cornerstone for the prevention of kidney damage. However, there are no well-defined practical hydration protocols available for the prevention of CI-AKI. The Prevention of Contrast Renal Injury with Different Hydration Strategies (POSEIDON) trial investigated a novel sliding scale hydration protocol based upon routine invasively obtained left ventricular end-diastolic pressure measurements (LVEDP) in patients undergoing cardiac catheterization.

Patients undergoing coronary angiography with stable renal insufficiency (an estimated GFR END

ELSE PRESS RELEASES FROM THIS DATE:

1-year results of ADAPT-DES presented at TCT 2012

2012-10-25

MIAMI, FL – OCTOBER 25, 2012 – Patients who receive a drug-eluting stent (DES) and demonstrate low levels of platelet inhibition are more likely to have blood clots form on the stent and suffer a possible heart attack; conversely, patients with higher levels of platelet inhibition are at greater risk for bleeding complications. One-year results of the ADAPT-DES study were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation, TCT is the world's premier educational meeting ...

Safety glass - cut to any shape

2012-10-25

If an object slams into the glass façade of a high-rise building, the glass must not shatter and fall down, because it could harm pedestrians below. In addition, the window panes must hold if a person were to fall against it from the inside. Architects and builders therefore must use something stronger than laminated safety glass on the façades of high rise buildings. The same applies to the windshields on cars. Safety glass prevents passengers in an accident from getting hurt by glass shards. And shop windows made of safety glass are expected to reliably safeguard the ...

"Spoon River Revisited" by Daniel J. Benor, MD: Messages From the Spirits - Halloween Launch From Wholistic Healing Publications

2012-10-25

One man's death is a tragedy; a million is a statistic. - Joseph Stalin This book of prose poems is a captivating visit to the legendary town of Spoon River, viewed through the epitaphs of its residents. SPOON RIVER REVISITED is an insightful sequel to Edgar Lee Master's 1916 classic, Spoon River Anthology. The people who share their modern stories still struggle with challenges of growing up, making their way through life, and passing on. Death has an undeserved, bad reputation! Within the understandings of western medicine, when the body stops working, that is ...

Timing is everything: Hormone use may reduce or increase Alzheimer's disease risk in women

2012-10-25

MINNEAPOLIS – A new study suggests that women who begin taking hormone therapy within five years of menopause may reduce their risk of developing Alzheimer's disease. The research is published in the October 24, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology. "This has been an area of debate because observational studies have shown a reduced risk of Alzheimer's disease with hormone therapy use, while a randomized controlled trial showed an increased risk. Our results suggest that there may be a critical window near menopause ...

Nearly 80 million Americans won't need vitamin D supplements under new guidelines

2012-10-25

MAYWOOD, Ill. - Nearly 80 million Americans would no longer need to take vitamin D supplements under new Institute of Medicine guidelines, according to a study by Loyola University Chicago Stritch School of Medicine researchers. Results were published Oct. 24, 2012 in the journal PLOS ONE. The new guidelines advise that almost all people get sufficient vitamin D when their blood levels are at or above 20 nanograms per milliliter (ng/ml). Older guidelines said people needed vitamin D levels above 30 ng/ml. Holly Kramer, MD, MPH and colleagues examined data from 15,099 ...

Genome analysis of pancreas tumors reveals new pathway

2012-10-25

HOUSTON -- (October 24, 2012) – , said a Baylor College of Medicine physician-scientist who was part of the local team that took part in the international effort. A report appears online in the journal Nature. "We now know every gene involved in pancreatic cancer," said Dr. William Fisher, professor of surgery and director of the Elkins Pancreas Center at BCM. "This study ushers in a whole new era of taking care of patients with pancreatic cancer. We will look back on this as a turning point in understanding and treating this disease." The study follows a five-year ...

Advanced cancer patients overoptimistic about chemotherapy's ability to cure, study finds

2012-10-25

BOSTON––Findings from a nationwide study led by researchers at Dana-Farber Cancer Institute suggest that patients with advanced lung or colorectal cancer are frequently mistaken in their beliefs that chemotherapy can cure their disease. The study, published in the Oct. 25 issue of the New England Journal of Medicine, found that 69 percent of patients with advanced lung cancer and 81 percent of patients with advanced colorectal cancer did not understand that the chemotherapy they were receiving was not at all likely to cure their disease. Their expectations run counter ...

Future training in bystander CPR needs targeted approach in 'high-risk' neighborhoods

2012-10-25

Residents living in high-income white and high-income integrated neighborhoods were more likely to receive bystander CPR (cardiopulmonary resuscitation) during an out-of-hospital cardiac arrest than arrest victims in low-income black neighborhoods, according to a publication in the Oct. 25 issue of the New England Journal of Medicine (NEJM). Arrest victims in low-income white, low-income integrated and high-income black neighborhoods were also less likely to receive bystander CPR. In an effort to look at future CPR training processes and public health planning, researchers ...

Prescription for palliative care: 4 points to improve discussions about dying

2012-10-25

In an editorial appearing in the October 25 issue of The New England Journal of Medicine, medical oncologists at Johns Hopkins and Brigham and Women's hospitals provide a four-point plan for integrating palliative care discussions throughout the treatment of patients with terminal illnesses. They write that better planning and communication may improve symptoms, stress, and survival time, as well as lower health care costs at the end of life. The two physicians suggest that their colleagues should discuss palliative care with patients during initial talks about prognosis ...

Gaps in border controls are related to alien insect invasions in Europe

2012-10-25

European countries with gaps in border security surrounding agricultural imports have been invaded by the largest number of exotic insect pests, according to research published Oct 24 in the open access journal PLOS ONE by Steven Bacon and colleagues from the Swiss Federal Research Station Agroscope ART and the University of Fribourg, Switzerland. Invasive agricultural pests pose growing environmental and economic problems, threatening biodiversity and costing billions of dollars in economic losses annually. Large volumes of cross-border trade increase the risks of invasion, ...

Results of the POSEIDON trial presented at TCT 2012

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: